文献速递生殖医学

美国私募股权附属生殖诊所的占比与表现

Prevalence and performance of private equity-affiliated fertility practices in the United States.
PubMed 文献 · Fertil Steril · 2021-09-15

该横断面分析基于美国CDC 2018年成功率报告数据,量化私募股权附属生殖诊所开展的辅助生殖技术(ART)周期比例,并比较其服务与成功率差异。结果显示14.7%的诊所与私募股权有关联,29.3%的ART周期在附属诊所完成,附属诊所更常使用胚胎植入前遗传学检测(PGT),但35岁以下女性成功率无显著差异。

要点

  • 14.7%的美国生殖诊所与私募股权有关联,承担29.3%的ART周期。
  • 附属诊所因男性因素不育启动周期的可能性低6.75%,使用PGT的可能性高10.60%。
  • 35岁以下女性在附属与非附属诊所的成功率无统计学显著差异。

核心结论

  • 美国相当部分生殖诊所与私募股权有关联,且其承担的ART周期比例更高。
  • 生殖医学可能是私募股权市场份额最大的医学专科。

研究设计与样本

  • 基于美国CDC 2018年生殖诊所成功率报告的横断面分析。
  • 共纳入305,883个ART周期,比较私募股权附属与非附属诊所。

主要发现

  • 14.7%的诊所具有私募股权关联,29.3%(89,535)的ART周期在附属诊所完成。
  • 附属诊所患者因男性因素不育启动周期的可能性低6.75%(95%CI -10.15%至-3.36%)。
  • 附属诊所患者在胚胎移植前使用PGT的可能性高10.60%(95%CI 3.49至17.76)。
  • 35岁以下女性成功率在附属与非附属诊所间无统计学显著差异。
  • 附属诊所所在邮编的平均家庭收入中位数为83,610美元(标准误35,990),非附属为72,161美元(标准误32,314)。

临床怎么用

  • 临床医生应了解所在或转诊生殖诊所的私募股权归属情况。
  • 咨询时可关注附属诊所PGT使用率较高及患者收入水平差异对服务的影响。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify the proportion of annual assisted reproductive technology (ART) cycles performed at private equity-affiliated fertility practices and to test for differences in services and success rates between private equity-affiliated and nonaffiliated practices. DESIGN: Cross-sectional analysis of national data set. SETTING: Not applicable. PATIENT(S): None. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): The primary outcome measures were the volume of ART cycles performed, the percentage of retrievals resulting in live births, and the percentage of transfers resulting in live births. The secondary outcomes included the median income of the practice location, the use of preimplantation genetic testing, the clinical service availability, and the patient reasons for seeking treatment. RESULT(S): Of the practices listed on the Centers for Disease Control's 2018 Fertility Clinic Success Rates Report, 14.7% had a private equity affiliation. Of the 305,883 ART cycles performed in 2018, 29.3% (89,535) occurred at private equity-affiliated practices. Patients at private equity-affiliated practices were 6.75% (95% confidence interval [CI], -10.15%, -3.36%) less likely to initiate a cycle due to male factor infertility, and 10.60% (95% CI, 3.49, 17.76) more likely to use preimplantation genetic testing before embryo transfer. No statistically significant differences were found in success rates among women aged <35 years. The average median household income (standard error) in zip codes with private equity-affiliated practices compared with nonaffiliated practices was $83,610 ($35,990) and $72,161 ($32,314), respectively. CONCLUSION(S): A major portion of fertility practices in the United States are private equity-affiliated, and these practices perform an even greater portion of ART cycles in the United States each year. Fertility appears to be the medical specialty with the greatest market share owned by private equity. Our findings corroborate preliminary research, which forecasts the increasing involvement and consolidation by private equity in fertility. Future research should continue monitoring for differences in outcomes, financing, case mix, service use, and accessibility.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Borsa A, Bruch JD. Prevalence and performance of private equity-affiliated fertility practices in the United States. Fertil Steril. 2021. PMID: 34538462. doi:10.1016/j.fertnstert.2021.08.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。